{
    "clinical_study": {
        "@rank": "60261", 
        "brief_summary": {
            "textblock": "This investigation is a prospective, non-randomized, multi-center trial to evaluate the\n      extended safety and performance of the HAART model 300 annuloplasty ring when used to\n      surgically repair the aortic valve using a 3-D intra-annular mounting frame."
        }, 
        "brief_title": "The HAART 300 Annuloplasty Ring Extended Safety and Performance Trial Used in Surgical Repair of the Aortic Valve", 
        "completion_date": {
            "#text": "May 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Aortic Insufficiency", 
        "condition_browse": {
            "mesh_term": "Aortic Valve Insufficiency"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Subject is 18 years of age or older\n\n          -  Subject has tri-leaflet aortic valve morphology\n\n          -  Subject has documented aortic valve disease which may or may not include:\n\n               1. aortic valve insufficiency\n\n               2. aortic root pathology\n\n               3. pathology of the ascending aorta\n\n               4. patients with associated stable one or two vessel coronary disease requiring\n                  concomitant coronary bypass\n\n          -  Subject is willing to comply with specified follow-up evaluations, including\n             transesophageal echocardiography (TEE) if there are inadequate images by\n             transthoracic echocardiography (TTE) to assess the aortic valve\n\n          -  Subject has reviewed and signed the written informed consent form\n\n          -  Subject agrees to return for all follow-up evaluations for the duration of the study\n             (i.e.,. geographically stable)\n\n        Exclusion Criteria:\n\n          -  The subject has pre-existing valve prosthesis in the aortic position\n\n          -  The subject's aortic valve morphology is not tri-leaflet\n\n          -  The subject has active endocarditis\n\n          -  Heavily calcified valves\n\n          -  The subject has mixed stenosis and regurgitation of the aortic valve with predominant\n             stenosis\n\n          -  Leukopenia\n\n          -  Acute anemia (Hb < 9mg%)\n\n          -  Platelet count <100,000 cell/mm3\n\n          -  Need for emergency surgery for any reason\n\n          -  History of bleeding diathesis or coagulopathy or the subject refuses blood\n             transfusions\n\n          -  Active infection requiring antibiotic therapy (if temporary illness, subjects may\n             enroll 4 weeks after discontinuation of antibiotics)\n\n          -  Subjects in whom transesophageal echocardiography (TEE) is contraindicated\n\n          -  Low Ejection Fraction (EF) EF < 35%\n\n          -  Life expectancy < 1 year\n\n          -  The subject is or will be participating in a concomitant research study of an\n             investigational product or has participated in such a study within the 30 days prior\n             to screening\n\n          -  The subject is a minor, an illicit drug user, alcohol abuser, prisoner,\n             institutionalized, or is unable to give informed consent\n\n          -  The subject is pregnant or lactating\n\n          -  Recent (within 6 months) cerebrovascular accident (CVA) or a transient ischemic\n             attack (TIA)\n\n          -  Myocardial Infarction (MI) within one month of trial inclusion\n\n          -  The subject has a known intolerance to titanium or polyester\n\n          -  The subject has documented unstable or > 2 vessel coronary disease\n\n          -  The subject requires additional valve replacement or valve repair"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "45", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 20, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01732835", 
            "org_study_id": "TP-01-022"
        }, 
        "intervention": {
            "intervention_name": "HAART 300 Annuloplasty Ring", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "Aortic Insufficiency (AI) Aortic Regurgitation (AR)", 
        "lastchanged_date": "January 10, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Prague", 
                        "country": "Czech Republic", 
                        "zip": "140 21"
                    }, 
                    "name": "Institute of Clinical and Experimental Medicine"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Berlin", 
                        "country": "Germany", 
                        "zip": "80636"
                    }, 
                    "name": "German Heart Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Freiburg", 
                        "country": "Germany", 
                        "zip": "79106"
                    }, 
                    "name": "Klinik f\u00fcr Herz und Gef\u00e4sschirurgie"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hamburg", 
                        "country": "Germany", 
                        "zip": "20246"
                    }, 
                    "name": "Klinik und Poliklinik f\u00fcr Herz- und Gef\u00e4\u00dfchirurgie"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hannover", 
                        "country": "Germany", 
                        "zip": "30625"
                    }, 
                    "name": "Hannover Medical School (MHH)"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "K\u00f6ln", 
                        "country": "Germany", 
                        "zip": "50937"
                    }, 
                    "name": "Uniklinik K\u00f6ln"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Munchen", 
                        "country": "Germany"
                    }, 
                    "name": "Munchen Heart Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "N\u00fcrnberg", 
                        "country": "Germany", 
                        "zip": "90471"
                    }, 
                    "name": "Klinikum N\u00fcrnberg S\u00fcd"
                }
            }
        ], 
        "location_countries": {
            "country": [
                "Czech Republic", 
                "Germany"
            ]
        }, 
        "number_of_arms": "1", 
        "official_title": "HAART 300 Trial Extended Safety and Performance", 
        "overall_official": {
            "affiliation": "Munchen Heart Center", 
            "last_name": "Dominico Mazzitelli, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "Germany: Federal Institute for Drugs and Medical Devices", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Survival defined as survival free from all cause death at 6 months post procedure", 
            "safety_issue": "Yes", 
            "time_frame": "6 months"
        }, 
        "removed_countries": {
            "country": "Belgium"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01732835"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Biostable Science & Engineering", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Biostable Science & Engineering", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "December 2012", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}